We investigated the protective effects against acute renal failure (ARF) of Anemarrhena asphodeloides (AA) and performed simultaneous analysis of three compounds, neomangiferin (1), mangiferin (2), and isomangiferin (3) in AA using a high-performance liquid chromatography-photodiode array. To measure the protective effect of ARF, the levels of reactive oxygen species (ROS) and glutathione depletion were determined using a kit. HPLC analysis was performed using a Gemini C 18 column at 40°C. The mobile phase used gradient elution with 1.0% (v/v) aqueous acetic acid (A) and 1.0% (v/v) acetic acid in acetonitrile (B). The flow rate was 1.0 mL/min. In our assay, AA extract inhibits cisplatin-induced production of intracellular ROS. Pre-incubation of AA extracts (10-200 g/mL) markedly maintained cell viability compared with controls in the noncisplatin-treated cells. Calibration curves of all compounds showed good linearity (r 2  0.9992). Recoveries of the three compounds were 98.9-103.4%. The relative standard deviations of intra-and inter-day precision were 0.07-1.73% and 0.12-1.49%, respectively. The amounts of the three components were 1.22-20.63 mg/g. The AA extract has potential as a therapeutic agent for treatment of ARF. In addition, the established method will help to improve quality control of AA.
Acute renal failure (ARF) is frequent in hospitalized critically ill patients, and mortality associated with ARF has remained largely unchanged over many decades. ARF is mainly characterized by acute tubular necrosis, which generates reactive oxygen species (ROS) and reduced glutathione (GSH) amounts. Progress in elucidation of ARF pathophysiology has led to the development and testing of many therapeutic drugs and other interventions in animal and human forms of acute tubular necrosis [1, 2] . Renal replacement therapy has promising features in the treatment of ARF, especially in the early stages. However, it was reported that the incidence and mortality rates of ARF have risen over the past two decades [3, 4] . Therefore, preventions of the occurrence and progression of ARF have become a very important issue. Currently, there are no specific or effective therapeutic agents to restrict renal injury and dysfunction of the kidney without side effects. Thus, there is a need to develop new protective agents that can prevent dysfunction of the kidney. Several clinical studies reported that oriental herbs show protective activity against oxidative stress and are potential therapeutic agents and many of them were successful in either preventing or counteracting some of the biochemical, physiological, and histological effects of ARF [5] .
Cisplatin (cis-diamminedichloroplatinum, CDDP)-induced ARF is characterized by decreased glomerular filtration rate, increases in body weight and GSH amount, increased oxidative stress, urinary concentration defects, and pathological changes that mainly occur in the S3 segment of the proximal tubule and the outer stripe of the outer medulla, which are known to be susceptible to an ischemic insult [1] . Analyses using serial sections also indicated that proximal tubular cells are mainly hypoxic in CDDP-induced ARF [6] . Indeed, experimental and clinical studies have shown that CDDP decreased the renal blood flow and glomerular filtration rate. Therefore, the present study was aimed at examining whether AA extract prevents CDDP-induced ROS and the decrease of antioxidant enzyme with cell viability.
The rhizome of Anemarrhena asphodeloides Bunge (AA, Liliaceae) is a perennial plant distributed in most regions of Korea, Japan, and China that has long been used in traditional medicine in these countries to treat chronic bronchitis and constipation [7] . AA has shown antidiabetic [8, 9] , anti-inflammatory [10] , anticancer [11] , antioxidant [12] , antiviral [13] , antifungal [14, 15] , and neuroprotective [16] effects. However, studies on the protective effects of AA against ARF have not been reported previously. Therefore, we examined whether an AA extract prevents CDDP-induced ROS, and the decrease of antioxidant enzyme and cell viability. In addition, we developed a simultaneous determination of three xanthones, neomangiferin (1), mangiferin (2), and isomangiferin (3), for quality control of AA using a high-performance liquid chromatography-photodiode array (HPLC-PDA) apparatus.
We obtained satisfactory separation using mobile phases consisting of 1.0%, v/v, aqueous acetic acid (A) and 1.0%, v/v, acetic acid in acetonitrile (B), with gradient elution. Each compound in the chromatogram was identified based on retention time, UV spectrum, and co-injection. A representative HPLC chromatogram of the extract is shown in Figure 1 and good separation of the three compounds form other components. The linearity regression equations (y = ax + b) were calculated between peak area (y) and concentration (x, g/mL) of the three reference compounds. The correlation coefficients (r 2 ) of the calibration curves for the compounds 1-3 were  0.9992 (Table 1 ). These results show that the calibration curves have good linearity. The LODs of compounds 1-3 were 0.02, 0.03, and 0.02 g/mL, respectively, and the LOQs of these compounds were 0.07, 0.11, and 0.07 g/mL, respectively ( Table 1 ). The recoveries of the three tested xanthones, compounds 1-3, were 96.0-103.9%, and the RSD range was 0.45-2.78% ( Table 2) . Repeatability or intra-assay precision was assessed using the RSDs of retention times and peak areas with six repeated measurements. The RSDs of the peak areas and retention times of the three analyzed compounds were not more than 1.0% and 0.5%, respectively. Therefore, this HPLC assay showed good repeatability under optimized conditions (data not shown). To test the precision of the established analytical method, intra-and inter-day variations in measurement of the three marker components were determined. The intra-and inter-day precisions of the method for simultaneous determination of the compounds 1-3 were 0.07-1.73% and 0.12-1.49%, respectively (Table 3) .
Our assay was subsequently applied to the simultaneous determination of the three components in AA. The amounts of the three xanthones were 1.22-20.63 mg/g and the RSDs were 0.17-1.09% (Table 4 ). A concentration-response curve of the AA extract was determined to evaluate its effect against CDDP-induced decrease in cell viability. Porcine renal epithelial cells (PK15) cells were incubated with CDDP and various AA extract concentrations were used ( Figure 2) . CDDP decreased the cell viability by 57.3% ( # p < 0.05, vs control) and this effect was partially prevented by co-incubation with AA extract; the decrease in cell viability was 18.5% ( Figures  3A and 3B) . This result is similar to the CDDP-alone treatment and CDDP-plus-AA-extract treatment. To confirm the effect of the AA extract on CDDP-induced cytotoxicity, the cell viability was measured using the crystal violet method. Renal PK15 epithelial cells showed 36.1% cell viability and CDDP-plus-AA-extracttreated cells 71.4% cell viability. ( # p < 0.05 vs control, *p < 0.05 vs CDDP-alone-treated group, Figures 4A and 4B , respectively). AA extract improved the cell viability of PK15 after CDDP treatment. Based on these results, AA extracts were used to evaluate their effect against CDDP-induced increased levels of ROS. CDDPinduced cell death is associated with ROS increase in the early stages of CDDP exposure. CDDP-induced cells showed a timedependent increase for 8 h from the early stage of exposure, which is the peak point of ROS generation, whereas CDDP-plus-AAextract treatment cells showed downregulation of ROS generation in the cells ( Figure 5A ). The antioxidant effect was also observed after 24 h because AA extract is able to reduce the decrease in GSH content. CDDP-exposed cells showed a decrease of 69.6% ( # p < 0.05 vs control, Figure 5B ) in GSH concentration while the decrease in GSH in CDDP-plus-AA-extract-treated cells showed an increase of 19.5% (*p < 0.05 vs CDDP-alone-treated group) in GSH content.
In this study, we examined if AA extract could be an important possible mediator in the ARF induced by CDDP, as a natural drug against ARF, which is characterized by a dramatically decreased glomerulus filtration rate, leading to retention of nitrogenous waste products, hyponatremia, and hyperkalemia [1, 3] . Accordingly, we used CDDP for mARFng the characteristic ARF, as a widely used chemotherapy drug, which is known to induce a reduction in antioxidant levels, leading to a failure of the antioxidant defense against free-radical damage. Furthermore, it has multiple intracellular effects, including the generation of ROS, reduction in GSH contents and stimulation of inflammation. Therefore, recently, many researchers have focused on traditional herbal medicines to find a novel therapeutic agent against ARF. In fact, various herbal medicines including pomegranate, Prosthechea michuacana, Prunus persica, and Zingiber officinale have proven protective effects against CDDP-induced ARF in in vitro experiments [17] [18] [19] . Therefore, we first investigated the effect of extracts from AA in ARF induced by CDDP. The results of this study indicate that AA extracts significantly attenuated the characteristic pathology of CDDP-induced ARF, which was evident from the elevation of antioxidant status with the reduction in ROS generation in the PK15 cells. The pathogenesis of CDDP-induced ARF remains to be elucidated clearly. Previous studies demonstrated that various factors, such as necrosis, apoptosis, vascular factors, inflammation, and oxidative stress, have been implicated in the pathogenesis of CDDP-induced ARF [20] . Recently, many studies have reported that oxidative stress is closely related to the development of CDDPinduced ARF. These findings are further supported by the studies that free-radical scavengers and antioxidants attenuated CDDPinduced ARF [21] . The ability of cells to enhance the level of GSH synthesis and then use the GSH for detoxification may be a key role in the protective mechanism against injury by chemical compounds [22, 23] . The decreased concentration of GSH increases the sensitivity of organs to oxidative and chemical injury. The level of renal GSH depletion could markedly increase the lipid peroxidation and nephrotoxicity induced by CDDP. In this study, administration of AA recovered the reduced GSH contents and increased ROS generation induced by CDDP treatment, which could partially explain the protection against oxidative stress induced by treatment with CDDP. Thus, the protective effects of AA against CDDPinduced ARF may be partially related to its antioxidant property. These antioxidant effects of AA have been proven by many experiments. In conclusion, our results suggest that AA extract may be protective against CDDP-induced ARF, possibly via elevation of antioxidant status.
In conclusion, simultaneous determination of the compounds 1-3 in AA was established and validated with respect to linearity, precision, and accuracy. The method will help to improve quality control of AA. In addition, this study demonstrates the protective effect of AA against ARF, suggesting that this herbal medicine has potential as a therapeutic agent for treatment of ARF.
This involves 24 h of incubation with CDDP and AA, using 50 L of AA on the 96-well plates with 1  10 4 porcine renal epithelial cells. After 2 h, CDDP (15 g/mL) was added to the 96-well plates. Cells were incubated in humidified air supplemented with 5% CO 2 at 37°C. Afterward, the EZ-Cytox cell viability assay kit was added to 10 L, and then after 4 h reactivation, MTT reduction was measured at a wavelength of 450 nm using a microplate reader.
Crystal violet staining: Cytotoxicity was measured using the crystal violet method. PK15 cells were seeded on 96-well plates and after 24 h of incubation, the cells were stained with 50 L crystal violet in methanol for 10 min at room temperature and then washed with tap water. The stained cells were extracted with 100 L of 1% sodium dodecyl sulfate, and dry extracts were measured at a wavelength of 570 nm using a Synergy HT multimode microplate reader (Biotek Instruments Inc, Winooski, VT, USA). The result is reported as viability with respect to the control.
ROS determination:
DCFH-DA (Invitrogen) was used as an intracellular ROS indicator. Cells were seeded on 96-well plates and after 24 h the cells were exposed to CDDP (15 g/mL) plus 50 L AA. Fluorescence was produced by oxidized DCFH and after 5 h, the fluorescence was measured with a microplate reader using excitation and emission wavelengths of 485 nm and 528 nm, respectively.
GSH content: GSH levels were measured using monochlorobimane employing a method previously described by Fernandez-Checa and Kaplowitz [24] , which has also been used for renal tissue. PK 15 cells were cultured onto a plastic plate at a density 2  10 6 cells/cm 2 . After the experimental protocol, the cells were washed twice with PBS, trypsinized, collected by centrifuging (12,000 rpm for 3 min) and then re-suspended using the buffer. The cells were sonicated and centrifuged at 10,000 g for 15 min at 4°C. The supernatant was incubated with monochlorobimane (1 mM) and glutathione S-transferase (1 U/mL) for 30 min in the dark. The fluorescence was measured using excitation and emission wavelengths of 360 nm and 460 nm, respectively using a Synergy HT multi-mode microplate reader (Biotek Instruments Inc).
